Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas

Dynamic contrast-enhanced (albumin-Gd-DTPA) magnetic resonance imaging, performed during 2 weeks of daily administration of an inhibitor of tyrosine kinase receptors (SU6668) in an HT-29 colon carcinoma model, revealed the onset of a hyper-enhancing rim, not observed in untreated tumours. To account...

Descripción completa

Detalles Bibliográficos
Autores principales: Farace, P, Galiè, M, Merigo, F, Daducci, A, Calderan, L, Nicolato, E, Degrassi, A, Pesenti, E, Sbarbati, A, Marzola, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696750/
https://www.ncbi.nlm.nih.gov/pubmed/19384298
http://dx.doi.org/10.1038/sj.bjc.6605041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696750/
https://www.ncbi.nlm.nih.gov/pubmed/19384298
http://dx.doi.org/10.1038/sj.bjc.6605041

Ejemplares similares